Serosurveillance after a COVID‐19 vaccine campaign in a Swiss police cohort. Issue 7 (6th June 2022)
- Record Type:
- Journal Article
- Title:
- Serosurveillance after a COVID‐19 vaccine campaign in a Swiss police cohort. Issue 7 (6th June 2022)
- Main Title:
- Serosurveillance after a COVID‐19 vaccine campaign in a Swiss police cohort
- Authors:
- Sendi, Parham
Thierstein, Marc
Widmer, Nadja
Babongo Bosombo, Flora
Büchi, Annina Elisabeth
Güntensperger, Dominik
Blum, Manuel Raphael
Baldan, Rossella
Tinguely, Caroline
Gahl, Brigitta
Heg, Dik
Theel, Elitza S.
Berbari, Elie
Endimiani, Andrea
Gowland, Peter
Niederhauser, Christoph - Abstract:
- Abstract: Introduction: To assess the risk for COVID‐19 of police officers, we are studying the seroprevalence in a cohort. The baseline cross‐sectional investigation was performed before a vaccination campaign in January/February 2021, and demonstrated a seroprevalence of 12.9%. Here, we demonstrate serosurveillance results after a vaccination campaign. Methods: The cohort consists of 1022 study participants. The 3‐ and 6‐month follow‐up visits were performed in April/May and September 2021. Data on infection and vaccination rates were obtained via measuring antibodies to the nucleocapsid protein and spike protein and online questionnaires. Results: The mean age of the population was 41 ( SD 8.8) years, 72% were male and 76% had no comorbidity. Seroconversion was identified in 1.05% of the study population at the 3‐month visit and in 0.73% at the 6‐month visit, resulting in an infection rate of 1.8% over a time period of 6 months. In comparison, the infection rate in the general population over the same time period was higher (3.18%, p = .018). At the 6‐month visit, 77.8% of participants reported being vaccinated once and 70.5% twice; 81% had an anti‐S antibody titer of >250 U/ml and 87.1% of ≥2 U/ml. No significant association between infection and job role within the department, working region, or years of experience in the job was found. Anti‐spike antibody titers of vaccinated study participants showed a calculated decreasing trend 150–200 days after the second vaccineAbstract: Introduction: To assess the risk for COVID‐19 of police officers, we are studying the seroprevalence in a cohort. The baseline cross‐sectional investigation was performed before a vaccination campaign in January/February 2021, and demonstrated a seroprevalence of 12.9%. Here, we demonstrate serosurveillance results after a vaccination campaign. Methods: The cohort consists of 1022 study participants. The 3‐ and 6‐month follow‐up visits were performed in April/May and September 2021. Data on infection and vaccination rates were obtained via measuring antibodies to the nucleocapsid protein and spike protein and online questionnaires. Results: The mean age of the population was 41 ( SD 8.8) years, 72% were male and 76% had no comorbidity. Seroconversion was identified in 1.05% of the study population at the 3‐month visit and in 0.73% at the 6‐month visit, resulting in an infection rate of 1.8% over a time period of 6 months. In comparison, the infection rate in the general population over the same time period was higher (3.18%, p = .018). At the 6‐month visit, 77.8% of participants reported being vaccinated once and 70.5% twice; 81% had an anti‐S antibody titer of >250 U/ml and 87.1% of ≥2 U/ml. No significant association between infection and job role within the department, working region, or years of experience in the job was found. Anti‐spike antibody titers of vaccinated study participants showed a calculated decreasing trend 150–200 days after the second vaccine dose. Conclusion: These data confirm the value of the vaccination campaign in an exposed group other than healthcare professionals. Graphical abstract: In this serosurveillance study, we observed a high vaccination and low infection rate during the delta surge in a police cohort. Anti‐Spike antibody titers of vaccinated study participants showed a calculated decreasing trend 150–200 days after the second vaccine dose. … (more)
- Is Part Of:
- Immunity, inflammation and disease. Volume 10:Issue 7(2022)
- Journal:
- Immunity, inflammation and disease
- Issue:
- Volume 10:Issue 7(2022)
- Issue Display:
- Volume 10, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 10
- Issue:
- 7
- Issue Sort Value:
- 2022-0010-0007-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-06-06
- Subjects:
- anti‐NCP‐antibodies -- anti‐S‐antibodies -- COVID‐19 seroprevalence -- SARS‐CoV‐2
Immunology -- Periodicals
Immunity -- Periodicals
Inflammation -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-4527 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.wileyopenaccess.com/view/journals.html ↗ - DOI:
- 10.1002/iid3.640 ↗
- Languages:
- English
- ISSNs:
- 2050-4527
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22257.xml